On Feb 1, 2022 ethris closed a Series B round and raised €23,300,000 from Laureus Capital, featuring lead investors Laureus Capital. About the company: ethris […]
Series A – Biofidelity
On Feb 1, 2022 Biofidelity closed a Series A round and raised $23,000,000 from Octopus Ventures, SBI Investment, featuring lead investors Octopus Ventures. About the […]
Series B – OLIPOP
On Feb 1, 2022 OLIPOP closed a Series B round and raised $30,000,000 from Adam Eskin, Anjula Acharia Bath, Brandon Shainfeld, Camilla Cabello, Deandre Hopkins, […]
Series A – Jasper Health
On Feb 1, 2022 Jasper Health closed a Series A round and raised $25,000,000 from 7wire Ventures, General Catalyst, Human Capital, Redesign Health, W Health […]
Series B – Simcha Therapeutics
On Jan 27, 2022 Simcha Therapeutics closed a Series B round and raised $40,000,000 from ArrowMark Partners, BVF Partners, Logos Capital, Rock Springs Capital, Samsara […]
Series A – Septerna
On Jan 27, 2022 Septerna closed a Series A round and raised $100,000,000 from BVF Partners, Casdin Capital, Catalio Capital Management, Invus, Logos Capital, Samsara […]
Series A – Kula Bio
On Jan 27, 2022 Kula Bio closed a Series A round and raised $50,000,000 from BOPU, Collaborative Fund, Embark Ventures, iSELECT FUND, Lowercarbon Capital, Neglected […]
Series A – TenSixteen Bio
On Jan 27, 2022 TenSixteen Bio closed a Series A round and raised $40,000,000 from Foresite Capital, GV, featuring lead investors Foresite Capital, GV. About […]
Series A – Ractigen Therapeutics
On Jan 27, 2022 Ractigen Therapeutics closed a Series A round and raised $30,000,000 from China Singapore Suzhou Industrial Park Ventures, Eisai, LC Ventures, SDIC […]
Series A – TenSixteen Bio
On Jan 27, 2022 TenSixteen Bio closed a Series A round and raised $40,000,000 from Foresite Capital, GV, featuring lead investors Foresite Capital, GV. About […]
